Linguistics professor examines manufacturers' prescription drug websites

June 30, 2010

Dartmouth Linguistics Professor Lewis Glinert and Jon Schommer, the associate head of the Department of Pharmaceutical Care and Health Systems at the University of Minnesota, have examined the corporate websites dedicated to the 100 best-selling prescription drugs. They found a startling lack of consistency in an industry where advertising standards are regulated by the Food and Drug Administration (FDA).

"Communicating via a website is common practice today," says Glinert, "and consumers are very savvy about doing their own research on the Internet. The FDA has rules about direct-to-consumer print and television , so we think it makes sense to also regulate websites and other marketing tools when it comes to prescription medicine. Consumers need consistent and balanced information."

Glinert presented their study, "Manufacturers' prescription drug web sites: A gray area of discourse and ethics," at the Communication, Medicine and Ethics (COMET) 2010 Conference at Boston University School of Public Health on June 28. Glinert and Schommer have previously published on the topic of direct-to-consumer drug advertising and Glinert has also presented their research at an FDA hearing.

In this paper, Glinert and Schommer found that the websites:

  • have no obvious linear narrative or 'next page' or conclusion; users move in a maze of text and navigation choices, some leading far away
  • lack a popular genre name (like infomercial), meaning that users come to them without a clear idea of how to perceive them
  • have an unpredictable mix of information and promotion, content, verbal style, visuals, and layout
  • often present safety and risk information in small font, in cumbersome un-bulleted blocks of text, detached from promotional text and videos, and below a page's scrolling 'fold'
Glinert notes that the Internet search engine Google has also been working to help consumers with their research on . A Google search of a prescription or generic drug name, for example Lipitor, will now display a summary and description at the top of the search results. The new feature, developed in partnership with the National Institutes of Health, links to NIH content and risk data.

"Our research provides justification for Google's move," says Glinert. "Only time will tell if this is a major change for the better."

Related Stories

Recommended for you

Fighting opioid addiction in primary care—new study shows it's possible

October 18, 2017
For many of the 2 million Americans addicted to opioids, getting good treatment and getting off prescription painkillers or heroin may seem like a far-off dream.

With no morphine, 25 million die in pain each year: report

October 13, 2017
Every year, some 25 million people—one in ten of them children—die in serious pain that could have been alleviated with morphine at just a few cents per dose, researchers said Friday.

Study finds few restrictions on Rx opioids through Medicare

October 9, 2017
Medicare plans place few restrictions on the coverage of prescription opioids, despite federal guidelines recommending such restrictions, a new Yale study finds. The research results highlight an untapped opportunity for ...

Nocebo effect: Does a drug's high price tag cause its own side effects?

October 5, 2017
Pricey drugs may make people more vulnerable to perceiving side effects, a new study suggests—and the phenomenon is not just "in their heads."

Pre-packaged brand version of compounded medication to prevent preterm births costs 5,000 percent more

October 2, 2017
Preventing a preterm birth could cost as little as $200 or as much as $20,000, depending on which one of two medications a doctor orders, according to a new analysis from Harvard Medical School.

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

yyz
5 / 5 (1) Jun 30, 2010
Because of confusing or misleading info presented at some company websites for specific drugs, I usually look for "prescribing info for doctors", usually in PDF format, which matches printed "bottle sheets" packaged with prescription medication or entries in the Physicians Desk Reference. While a few companies may obfuscate or delay FDA mandated changes in this information( such as warning boxes ), you can at least find the most recent information being packaged with the medication (look for dates at the beginning or end of the PDF file).

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.